Research article · 12 Jun 2025
Conference abstractPublished 2017
Pharmacokinetics of a doxorubicin loaded porphyrin-phospholipid liposome in wistar rats
Nanotechnology Characterization Lab, USA University at Buffalo, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
A doxorubicin (DXR) loaded porphyrin-phospholipid (PoP) liposome is currently under development for light-triggered drug release in solid tumors. In order for the light-triggered drug release concept to be viable, the DXR-PoP liposome must remain stable in vivo, and not undergo premature release of the encapsulated therapeutic payload, DXR, or the lipid bilayer loaded photoactivatable agent, PoP. The objective of the present study was to determine the in vivo stability of the construct by characterizing the pharmacokinetic profile of both the DXR and PoP components in 10-week-old, double jugular catheterized, and male Fischer 344 rats. A group of 8 rats were administered 5 mg DXR/kg of the DXR-PoP liposome i.v., and blood was collected at 0.25, 0.5, 1, 4, 8, 12, 24, 48, and 96 h time-points for preparation of plasma. Plasma samples underwent analysis for PoP and DXR by mass spectrometry. Plasma profiles for the PoP and DXR analytes were identical when presented on a % dose/mL basis. Similarly, pharmacokinetic parameters, as determined by non-compartmental analysis using Phoenix WinNonlin software, were identical for DXR and PoP. Mean clearance, volume of distribution steady state, mean residence time and half-life ranged were 1.16+0.1 mL/h/kg, 41+4 mL/kg, 33+2 h, and 26+1.2 h for DXR, and 1.33+0.1 mL/h/kg, 45+5 mL/kg, 32+2 h, and 25+1.4 h for POP. These data support the integrity of the DXR-PoP liposome construct upon in vivo administration, and the concept of light-triggered drug release.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Pharmaceutics & Drug Delivery Research.
Research article · 20 Feb 2025
Sustained Drug Delivery in Pharmaceutical Dosage Forms for Novel Approaches of Formulation Design
Research article · 23 Jan 2025
Cutting Out Counterfeits: How Blockchain Can Revolutionize Drug Traceability?
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pharmaceutics & Drug Delivery Research
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “S Skoczen”
- BylineArticles whose byline prints “K S Snapp”
- BylineArticles whose byline prints “D Luo”
- BylineArticles whose byline prints “J F Lovell”
- BylineArticles whose byline prints “S T Stern”
